Condition
Ethanol Intoxication
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 1 (1)
Trial Status
Completed3
Terminated1
Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07779967Not ApplicableRecruiting
Alcohol, Breast Cancer, and Metabolism
NCT06091189Early Phase 1Terminated
Internalized Stress in Relation to Alcohol Consumption
NCT05715723CompletedPrimary
Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication
NCT05487404Phase 1CompletedPrimary
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels
NCT05911282Not ApplicableCompletedPrimary
N-acetylcysteine Reduces Acetaldehyde Levels in Binge Alcohol Drinking
Showing all 5 trials